These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 31722348

  • 1. Survey of Mast Cell Mediator Levels from Patients Presenting with Symptoms of Mast Cell Activation.
    Butterfield JH.
    Int Arch Allergy Immunol; 2020; 181(1):43-50. PubMed ID: 31722348
    [Abstract] [Full Text] [Related]

  • 2. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
    Ravi A, Butterfield J, Weiler CR.
    J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
    [Abstract] [Full Text] [Related]

  • 3. Mast Cell Mediators of Significance in Clinical Practice in Mastocytosis.
    Butterfield JH, Ravi A, Pongdee T.
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):397-410. PubMed ID: 30007459
    [Abstract] [Full Text] [Related]

  • 4. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
    Divekar R, Butterfield J.
    Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
    [Abstract] [Full Text] [Related]

  • 5. Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome.
    Butterfield JH.
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2542-2546. PubMed ID: 36863614
    [Abstract] [Full Text] [Related]

  • 6. Increased leukotriene E4 excretion in systemic mastocytosis.
    Butterfield JH.
    Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):73-6. PubMed ID: 20380889
    [Abstract] [Full Text] [Related]

  • 7. The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome.
    Butterfield J, Weiler CR.
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2533-2541. PubMed ID: 32142966
    [Abstract] [Full Text] [Related]

  • 8. Urine Mast Cell Mediators in the Evaluation and Diagnosis of Mast Cell Activation Syndrome.
    Voelker D, Pongdee T.
    Curr Allergy Asthma Rep; 2024 Feb; 24(2):33-38. PubMed ID: 38236528
    [Abstract] [Full Text] [Related]

  • 9. Divergent PGD2 and leukotriene C4 metabolite excretion following aspirin therapy: Ten patients with systemic mastocytosis.
    Butterfield JH, Singh RJ.
    Prostaglandins Other Lipid Mediat; 2021 Aug; 155():106563. PubMed ID: 34029712
    [Abstract] [Full Text] [Related]

  • 10. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma.
    Mita H, Endoh S, Kudoh M, Kawagishi Y, Kobayashi M, Taniguchi M, Akiyama K.
    Allergy; 2001 Nov; 56(11):1061-7. PubMed ID: 11703219
    [Abstract] [Full Text] [Related]

  • 11. Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis.
    Lueke AJ, Meeusen JW, Donato LJ, Gray AV, Butterfield JH, Saenger AK.
    Clin Biochem; 2016 Sep; 49(13-14):979-82. PubMed ID: 26908217
    [Abstract] [Full Text] [Related]

  • 12. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
    Butterfield JH, Weiler CR.
    Int Arch Allergy Immunol; 2008 Sep; 147(4):338-43. PubMed ID: 18622141
    [Abstract] [Full Text] [Related]

  • 13. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis.
    Ono E, Taniguchi M, Mita H, Fukutomi Y, Higashi N, Miyazaki E, Kumamoto T, Akiyama K.
    Clin Exp Allergy; 2009 Jan; 39(1):72-80. PubMed ID: 19128354
    [Abstract] [Full Text] [Related]

  • 14. Nontryptase Urinary and Hematologic Biomarkers of Mast Cell Expansion and Mast Cell Activation: Status 2022.
    Butterfield JH.
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1974-1984. PubMed ID: 35346887
    [Abstract] [Full Text] [Related]

  • 15. Differential mast cell mediators in systemic mastocytosis and hereditary α-tryptasemia.
    Giannetti MP, Godwin G, Weller E, Butterfield JH, Castells M.
    J Allergy Clin Immunol; 2022 Nov; 150(5):1225-1227. PubMed ID: 35550148
    [Abstract] [Full Text] [Related]

  • 16. Evidence for mast cell activation during exercise-induced bronchoconstriction.
    O'Sullivan S, Roquet A, Dahlén B, Larsen F, Eklund A, Kumlin M, O'Byrne PM, Dahlén SE.
    Eur Respir J; 1998 Aug; 12(2):345-50. PubMed ID: 9727783
    [Abstract] [Full Text] [Related]

  • 17. Mast Cell Activation Syndrome.
    Frieri M.
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):353-365. PubMed ID: 25944644
    [Abstract] [Full Text] [Related]

  • 18. A US-Based Multicenter Retrospective Report of Perioperative Anaphylaxis, 2010-2021.
    Gonzalez-Estrada A, Carrillo-Martin I, Morgenstern-Kaplan D, Rukasin CRF, Rank MA, Park MA, Yee CI, Volcheck GW.
    J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1594-1602.e9. PubMed ID: 38580206
    [Abstract] [Full Text] [Related]

  • 19. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M, Butterfield J.
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [Abstract] [Full Text] [Related]

  • 20. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions.
    O'Sullivan S, Roquet A, Dahlén B, Dahlén S, Kumlin M.
    Clin Exp Allergy; 1998 Nov; 28(11):1332-9. PubMed ID: 9824404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.